<VariationArchive VariationID="1416748" VariationName="NM_000528.4(MAN2B1):c.256dup (p.Tyr86fs)" VariationType="Duplication" Accession="VCV001416748" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1487488" VariationID="1416748">
      <GeneList>
        <Gene Symbol="MAN2B1" FullName="mannosidase alpha class 2B member 1" GeneID="4125" HGNC_ID="HGNC:6826" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12646512" stop="12666742" display_start="12646512" display_stop="12666742" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12757321" stop="12777590" display_start="12757321" display_stop="12777590" Strand="-" />
          </Location>
          <OMIM>609458</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000528.4(MAN2B1):c.256dup (p.Tyr86fs)</Name>
      <CanonicalSPDI>NC_000019.10:12665708:AAAA:AAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19p13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12665708" stop="12665709" display_start="12665708" display_stop="12665709" variantLength="1" positionVCF="12665708" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12776522" stop="12776523" display_start="12776522" display_stop="12776523" variantLength="1" positionVCF="12776522" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>Y86fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.12665712dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.12665712dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.12776526dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.12776526dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008318.1" sequenceAccession="NG_008318" sequenceVersion="1" change="g.6069dup">
            <Expression>NG_008318.1:g.6069dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015814.1" sequenceAccession="NG_015814" sequenceVersion="1" change="g.3909dup">
            <Expression>NG_015814.1:g.3909dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000528.4" sequenceAccession="NM_000528" sequenceVersion="4" change="c.256dup" MANESelect="true">
            <Expression>NM_000528.4:c.256dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000519.2" sequenceAccession="NP_000519" sequenceVersion="2" change="p.Tyr86fs">
            <Expression>NP_000519.2:p.Tyr86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001173498.2" sequenceAccession="NM_001173498" sequenceVersion="2" change="c.256dup">
            <Expression>NM_001173498.2:c.256dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001166969.1" sequenceAccession="NP_001166969" sequenceVersion="1" change="p.Tyr86fs">
            <Expression>NP_001166969.1:p.Tyr86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2024217430" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000528.4(MAN2B1):c.256dup (p.Tyr86fs) AND Deficiency of alpha-mannosidase" Accession="RCV001947965" Version="3">
        <ClassifiedConditionList TraitSetID="428">
          <ClassifiedCondition DB="MedGen" ID="C0024748">Deficiency of alpha-mannosidase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22161967</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9915946</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="428" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2728" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lysosomal alpha-D-mannosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha mannosidase B deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mannosidosis, alpha B lysosomal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of alpha-mannosidase</ElementValue>
                <XRef ID="Alpha-Mannosidosis+Type+1/332" DB="Genetic Alliance" />
                <XRef ID="124466001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha-Mannosidosis</ElementValue>
                <XRef ID="NBK1396" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MANSA</ElementValue>
                <XRef Type="MIM" ID="248500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6968" />
                <XRef ID="6968" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-mannosidosis encompasses a continuum of clinical findings from mild to severe. Three major clinical subtypes have been suggested: A mild form recognized after age ten years with absence of skeletal abnormalities, myopathy, and slow progression (type 1). A moderate form recognized before age ten years with presence of skeletal abnormalities, myopathy, and slow progression (type 2). A severe form manifested as prenatal loss or early death from progressive central nervous system involvement or infection (type 3). Individuals with a milder phenotype have mild-to-moderate intellectual disability, impaired hearing, characteristic coarse features, clinical or radiographic skeletal abnormalities, immunodeficiency, and primary central nervous system disease â€“ mainly cerebellar involvement causing ataxia. Periods of psychiatric symptoms are common. Associated medical problems can include corneal opacities, hepatosplenomegaly, aseptic destructive arthritis, and metabolic myopathy. Alpha-mannosidosis is insidiously progressive; some individuals may live into the sixth decade.</Attribute>
                <XRef ID="NBK1396" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301570</ID>
                <ID Source="BookShelf">NBK1396</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21368911</ID>
              </Citation>
              <XRef ID="61" DB="Orphanet" />
              <XRef ID="C0024748" DB="MedGen" />
              <XRef ID="MONDO:0009561" DB="MONDO" />
              <XRef Type="MIM" ID="248500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4214317" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="14510984|MedGen:C0024748" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002195084" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9915946</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22161967</ID>
          </Citation>
          <Comment>This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Tyr86Leufs*6) in the MAN2B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MAN2B1 are known to be pathogenic (PMID: 9915946, 22161967). This variant has not been reported in the literature in individuals affected with MAN2B1-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MAN2B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.12776522_12776523insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024748" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4214317" TraitType="Disease" MappingType="XRef" MappingValue="C0024748" MappingRef="MedGen">
        <MedGen CUI="C0024748" Name="Deficiency of alpha-mannosidase" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

